These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Traceless solid-phase synthesis of 6-amino- and 6-hydroxyimino-1,3,5-triazine-2,4-diones and 1,3,5-triazine-2,4,6-triones. Kong KH; Tan CK; Lam Y J Comb Chem; 2009; 11(6):1050-60. PubMed ID: 19817460 [TBL] [Abstract][Full Text] [Related]
12. Efficient synthesis of bicyclic oxazolino- and thiazolino[3,2-c]pyrimidine-5,7-diones and its application to the synthesis of GnRH antagonists. Pontillo J; Chen C Bioorg Med Chem Lett; 2005 Mar; 15(5):1407-11. PubMed ID: 15713397 [TBL] [Abstract][Full Text] [Related]
13. Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists. Lanier MC; Feher M; Ashweek NJ; Loweth CJ; Rueter JK; Slee DH; Williams JP; Zhu YF; Sullivan SK; Brown MS Bioorg Med Chem; 2007 Aug; 15(16):5590-603. PubMed ID: 17561404 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism. Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists. Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity. Krauth F; Dahse HM; Rüttinger HH; Frohberg P Bioorg Med Chem; 2010 Mar; 18(5):1816-21. PubMed ID: 20153202 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1,2,4-triazine derivatives as potential anti-anxiety and anti-inflammatory agents. Mullick P; Khan SA; Begum T; Verma S; Kaushik D; Alam O Acta Pol Pharm; 2009; 66(4):379-85. PubMed ID: 19702169 [TBL] [Abstract][Full Text] [Related]
18. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines. Arya K; Dandia A Bioorg Med Chem Lett; 2007 Jun; 17(12):3298-304. PubMed ID: 17449247 [TBL] [Abstract][Full Text] [Related]
20. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists. Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]